{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:01:32Z","timestamp":1789790492862,"version":"4.0.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001315","name":"University of Hertfordshire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001315","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Earlier comparative scholarship on physician regulation has revealed marked differences in disciplinary outcomes between the United States (US) and Great Britain (GB), the latter of which imposes more severe sanctions for comparable misconduct. This article extends the inquiry into pharmacy regulation to determine whether the identified divergence is unique to medical regulation, or whether it is representative of broader features of the procedural structures that govern professional discipline, by comparing the disciplinary outcomes from each of the US and GB for a 10-year period concluding with the latest publicly available data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A quantitative comparative analysis was undertaken on a dataset comprising of disciplinary decisions issued over a ten-year period concluding in June 2025: a total of 22 129 cases; 21 561 (97%) of which occurred in the US and 1868 (3%) in GB. Sanctions were coded into four condensed categories: warnings, conditions, suspension, and erasure, and analyzed using Pearson's chi-squared testing to assess differences in disciplinary severity between the jurisdictions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>The results revealed a significant transatlantic difference in disciplinary outcomes against pharmacy practitioners: 79% of GB cases resulted in severe sanctions, whilst only 38% of US cases did so, with lenient sanctions prevailing in the US, closely replicating earlier findings relating to the discipline of doctors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>While some level of self-regulation is inherent to being a profession, the current extent in the US is excessive. Although professional autonomy is deeply rooted, it shouldn\u2019t be immune to reform, especially given growing evidence that professions are failing to uphold their responsibilities to the public. It is evident that our findings are not profession-specific, instead pointing to wider features of regulatory design and execution. This study contributes new empirical evidence to scholarship on the design of professional regulatory structures and cross-jurisdictional consistency in professional discipline and highlights the need for further research into the correlation between regulatory design and disciplinary outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijpp\/riag135","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:39:35Z","timestamp":1788521975000},"source":"Crossref","is-referenced-by-count":0,"title":["A comparative analysis of disciplinary outcomes for pharmacy professions in the United States and Great Britain"],"prefix":"10.1093","author":[{"given":"Denzil","family":"Johnson","sequence":"first","affiliation":[{"name":"School of Health , Medicine and Life Sciences, University of Hertfordshire, Hatfield, Herts, AL10 9AB, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8378-5987","authenticated-orcid":false,"given":"Nkiruka","family":"Umaru","sequence":"additional","affiliation":[{"name":"School of Health, Medicine and Life Sciences , University of Hertfordshire, Hatfield, Herts, AL10 9AB, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2107-4522","authenticated-orcid":false,"given":"Cathal T","family":"Gallagher","sequence":"additional","affiliation":[{"name":"School of Health , Medicine and Life Sciences, University of Hertfordshire, Hatfield, Herts, AL10 9AB, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"2026091823015625300_ref1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1017\/amj.2025.17","article-title":"Doctors playing lawyers: lessons for professional regulation in crisis","volume":"51","author":"Allensworth","year":"2025","journal-title":"American Journal of Law & Medicine"},{"key":"2026091823015625300_ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/20479700.2025.2565737","article-title":"Two nations separated by a common goal: comparing the severity of penalties against doctors at disciplinary hearings in the United States and United Kingdom","author":"Gallagher","year":"2025","journal-title":"Int J Healthc Manag"},{"key":"2026091823015625300_ref3","volume-title":"Washington","author":"State Discipline of Pharmacists","year":"2019"},{"key":"2026091823015625300_ref4","volume-title":"The Regulation of Health Professionals in the 21st Century, Cm 7013","author":"Trust, Assurance and Safety","year":"2007"},{"key":"2026091823015625300_ref5","author":"GPhC registers data"},{"key":"2026091823015625300_ref6","volume-title":"Occupational Employment and Wage Statistics (Pharmacists)","author":"Bureau of Labor Statistics","year":"2023"},{"key":"2026091823015625300_ref7","author":"Pharmacy Order 2010\/231","year":"2026"},{"key":"2026091823015625300_ref8","author":"Pharmacy (Northern Ireland) Order 1976\/1213","year":"2026"},{"key":"2026091823015625300_ref9","author":"Medical Act 1858","year":"2026"},{"key":"2026091823015625300_ref10","author":"Health Act 1999","year":"2026"},{"key":"2026091823015625300_ref11","author":"Pharmacy and Poisons Order (Northern Ireland) 1925\/161","year":"2026"},{"key":"2026091823015625300_ref12","author":"Pharmacists and Pharmacy Technicians Order 2007\/289","year":"2026"},{"key":"2026091823015625300_ref13","doi-asserted-by":"publisher","first-page":"100818","DOI":"10.1016\/j.rcsop.2026.100818","article-title":"Contours of the transatlantic regulatory landscape: a research agenda towards the reform of US state pharmacy board disciplinary functions","volume":"23","author":"Johnson","year":"2026","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"key":"2026091823015625300_ref14","author":"General Pharmaceutical Council (Statutory Committees and their Advisers Rules) Order of Council 2010\/1616","year":"2026"},{"key":"2026091823015625300_ref15","author":"Upholding Standards in Public Life","year":"2021"},{"key":"2026091823015625300_ref16","author":"2025 Survey of Pharmacy Law","year":"2025"},{"key":"2026091823015625300_ref17","volume-title":"Fitness to Practise Hearings and Outcomes Guidance","author":"Good decision making","year":"2024"},{"key":"2026091823015625300_ref18","author":"Healthcare regulation: deciding when statutory regulation is appropriate","year":"2022"},{"key":"2026091823015625300_ref19","author":"Professional healthcare regulation in the UK explained","year":"2018"},{"key":"2026091823015625300_ref20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/ACM.0b013e3181a3db32","article-title":"Commentary: granting medical licensure, Honoring the Americans with disabilities act, and protecting the public: can we do all three?","volume":"84","author":"Altchuler","year":"2009","journal-title":"Acad Med"},{"key":"2026091823015625300_ref21","author":"Council of the Pharmaceutical Society of Northern Ireland (Statutory Committee, Scrutiny Committee and Advisers) Regulations (Northern Ireland) 2012\/310","year":"2026"},{"key":"2026091823015625300_ref22","author":"General Pharmaceutical Council (Registration Rules) Order of Council 2010\/1617","year":"2010"},{"key":"2026091823015625300_ref23","volume-title":"Title 22, Part 15","author":"Texas Administrative Code"},{"key":"2026091823015625300_ref24","volume-title":"DC Law 6\u201399, 33 DC Reg. 729","author":"Health Occupations Revision Act 1985","year":"1986"},{"key":"2026091823015625300_ref25","volume-title":"Division 2, Chapter 9","author":"California Business and Professions Code"},{"key":"2026091823015625300_ref26","first-page":"157","article-title":"X. On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. The London, Edinburgh, and Dublin philosophical magazine and journal of","volume":"50","author":"Pearson","year":"1900","journal-title":"Science"},{"key":"2026091823015625300_ref27","volume-title":"The New York Review of Books","author":"Allensworth","year":"2020"},{"key":"2026091823015625300_ref28","author":"Allensworth"},{"key":"2026091823015625300_ref29","volume-title":"Occupational Outlook Handbook (Pharmacists)","author":"Bureau of Labor Statistics","year":"2025"},{"key":"2026091823015625300_ref30","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.japh.2022.12.013","article-title":"Minding the gap and the value of metrics: count of working pharmacists in the United States","volume":"63","author":"Hirsch","year":"2023","journal-title":"J Am Pharm Assoc"},{"key":"2026091823015625300_ref31","first-page":"41","author":"Chaudhury v General Medical Council [2002]","journal-title":"UKPC"},{"key":"2026091823015625300_ref32","author":"Giele v General Medical Council [2005] EWHC 2143 (Admin)"},{"key":"2026091823015625300_ref33","volume-title":"Fitness to Practise Hearings and Outcomes Guidance","author":"Good decision making","year":"2024"},{"key":"2026091823015625300_ref34","volume-title":"Preventing Regulatory Capture: Special Interest Influence and how to Limit it","author":"Carpenter","year":"2014"},{"key":"2026091823015625300_ref35","author":"Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy","year":"2025"},{"key":"2026091823015625300_ref36","doi-asserted-by":"crossref","first-page":"A72","DOI":"10.1186\/s12960-020-00501-y","article-title":"Health professional regulation in historical context: Canada, the USA and the UK (19th century to present)","volume":"18","author":"Adams","year":"2020","journal-title":"Hum Resour Health"},{"key":"2026091823015625300_ref37","author":"General Medical Council (Fitness to Practise) Rules Order of Council 2004\/2608","year":"2026"},{"key":"2026091823015625300_ref38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bmj.325.7360.397","article-title":"The GMC is too lenient","volume":"325","author":"Wilmshurst","year":"2002","journal-title":"The British Medical Journal"},{"key":"2026091823015625300_ref39","volume":"25","journal-title":"Int J Pharm Pract"},{"key":"2026091823015625300_ref40","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1287\/orsc.2023.17932","article-title":"\u201cIt takes more than a pill to kill\u201d: bounded accountability in disciplining professional misconduct despite heightened transparency","volume":"35","author":"Kaynak","year":"2024","journal-title":"Organ Sci"},{"key":"2026091823015625300_ref41","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.socscimed.2011.08.031","article-title":"Why is UK medicine no longer a self-regulating profession? The role of scandals involving \"bad apple\" doctors","volume":"73","author":"Dixon-Woods","year":"2011","journal-title":"Soc Sci Med"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article-pdf\/doi\/10.1093\/ijpp\/riag135\/71228055\/riag135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article-pdf\/doi\/10.1093\/ijpp\/riag135\/71228055\/riag135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:02:14Z","timestamp":1789786934000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/advance-article\/doi\/10.1093\/ijpp\/riag135\/8817556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1093\/ijpp\/riag135","relation":{},"ISSN":["2042-7174"],"issn-type":[{"value":"2042-7174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"riag135"}}